Champions Sports, Inc. Changes Name to Champions Biotechnology, Inc.

ARLINGTON, Va., Jan. 22  /PRNewswire-FirstCall/ -- Champions Sports, Inc. (OTC:CSBR) (BULLETIN BOARD: CSBR) , announced today the change of its name to Champions Biotechnology, Inc. The Company sold its Champions service mark and concept for sports themed restaurants to Marriott International, Inc. in 1997 and has since been seeking a new business direction. The change of name is intended reflect the decision of the Company to focus on biotechnology as its new business approach.

Recently, Dr. David Sidransky and Dr. Manuel Hidalgo, both with established credentials in the field of biotechnology, have become major investors with the Company. The management and owners of the Company intend to use their expertise to build a biotechnology company and have decided to seek ventures in that field.

The change of name to Champions Biotechnology, Inc. has been filed with the State of Delaware.

This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties. The Company generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors, which may include, but are not limited to, changes in general economic conditions, the ongoing threat of terrorism, ability to have access to financing sources on reasonable terms and other risks that are described in this document. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and the Company's future results, levels of activity, performance or achievements may not meet these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in the Company's expectations, except as required by law.

CONTACT: James Martell of Champions Biotechnology, Inc. (703)-526-0400. 

DATASOURCE: Champions Biotechnology, Inc.



CONTACT:  James Martell of Champions Biotechnology, Inc.,

[phone]

Copyright